Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mycol Med ; 31(2): 101113, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33540367

RESUMO

INTRODUCTION: Cryptococcus gattii species complex is endemic to tropical and subtropical regions and is described as a causative agent of cryptococcosis in immunocompetent individuals. CASE PRESENTATION: We describe the first case of cryptococcosis in a HIV-negative patient from Ivory Coast infected by Cryptococcus gattii sensu stricto VGI. Isolates were recovered from cerebrospinal fluid (CSF) prior to systemic antifungal treatment up to 42 days after detection of the presence of yeasts in the CSF. Eighteen isolates were recovered, genetic diversity and antifungal susceptibility analyses were performed. All the isolates belonged to the Cryptococcus gattii sensu stricto (B;VGI) and were identified as a new sequence type (ST) 553 by Multilocus Sequence Typing (MLST) analyses. Susceptibility testing showed that all the strains had a wild-type phenotype for fluconazole, amphotericin B and flucytosine. Treatment with fluconazole (1200mg/day) was initiated with success. CONCLUSION: This is the first case report of the presence of C. gattii sensu stricto VGI in a HIV-negative ivorian patient and the second report of the presence of species from the C. gattii complex species in this country.


Assuntos
Antifúngicos/farmacologia , Criptococose/diagnóstico , Cryptococcus gattii/efeitos dos fármacos , Cryptococcus gattii/genética , Genótipo , Adulto , Antifúngicos/uso terapêutico , Côte d'Ivoire , Criptococose/líquido cefalorraquidiano , Criptococose/tratamento farmacológico , Criptococose/microbiologia , Cryptococcus gattii/classificação , Cryptococcus gattii/patogenicidade , Feminino , Variação Genética , Infecções por HIV , Humanos , Testes de Sensibilidade Microbiana
2.
J Mycol Med ; 27(1): 72-78, 2017 Mar.
Artigo em Francês | MEDLINE | ID: mdl-28108201

RESUMO

OBJECTIVE: Assessing the use of high-dose fluconazol monotherapy (1200mg or 800mg) in the treatment and prognosis of HIV-associated cryptococcal meningitis in Ivory Coast. PATIENTS AND METHODS: A retrospective study carried out from August 2008 to August 2011 based on patients charts suffering from CM in the Abidjan Tropicals and Infectious Disease Unit. Mortality rate and associated factors were analyzed. RESULTS: Forty-six cases of cryptococcal meningitis (2.5% of hospitalizations) were included. The sex-ratio was of 1.2. The median age was 40.5 [35-47] years. The symptomatology was subacute (93.5%). The main clinical symptoms were syndrome of pure meningeal irritation (65%), fever (100%); 35% of patients had encephalomeningits. Twenty-one (45.7%) was ART-naïve patients. Fluconazole 1200mg was prescribed to 29 (63%) patients. Therapeutic lumbar punctures were performed in 42 (91.3) patients. The mortality rate was 50%. Significant predictors of mortality were encephalomeningitis and therapeutic lumbar puncture. CONCLUSION: Cryptococcal meningitis associated mortality remains high despite the use of high-dose fluconazole monotherapy. Therapeutic lumbar punctures help to improving the prognosis.


Assuntos
Antifúngicos/administração & dosagem , Fluconazol/administração & dosagem , Meningite Criptocócica/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Adulto , Côte d'Ivoire/epidemiologia , Relação Dose-Resposta a Droga , Feminino , HIV , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Humanos , Masculino , Meningite Criptocócica/epidemiologia , Pessoa de Meia-Idade , Estudos Retrospectivos
3.
Med Mal Infect ; 45(8): 324-7, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26344815

RESUMO

OBJECTIVE: We described the use of antiretroviral drugs to prevent HIV transmission among children and adolescents victims of rape in Abidjan (Ivory Coast). MATERIALS AND METHOD: We conducted a retrospective and descriptive study on children (0-9 years) and adolescents (10-19 years) victims of rape between 2000 and 2013. We analyzed the patients' socio-demographic characteristics and the modality of the chemoprophylaxis. RESULTS: We included 10 children and 89 adolescents in the study. The median age was 16 years old (3-19 years). The median time to consultation was 23.5 hours (5-152 hours). The antiretroviral chemoprophylaxis was administered to 92 patients (93%). No HIV and HBV seroconversion was observed after a 3-month follow-up. CONCLUSION: A better management of rape victims is required in Abidjan.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/prevenção & controle , Estupro , Adolescente , Fármacos Anti-HIV/administração & dosagem , Criança , Pré-Escolar , Côte d'Ivoire , Feminino , Seguimentos , Anticorpos Anti-HIV/sangue , Infecções por HIV/transmissão , Soropositividade para HIV , Necessidades e Demandas de Serviços de Saúde , Hepatite B/transmissão , Anticorpos Anti-Hepatite B/sangue , Humanos , Masculino , Estudos Retrospectivos , Soroconversão , Fatores Socioeconômicos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...